A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Players like Kerry Goode. The pride of Hazelwood High School once dreamed of plunging into the endzone and helping his team ...

ZEPHYRHILLS — Former Zephyrhills High football coach Tom Fisher, who spent the better part of two decades carving highly ...

The crowd surged into the freezing Atlantic Ocean in the latest in a series of winter plunges at the Jersey Shore.

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Repeated brain injury resulted in SOD1-ALS mice showing greater weight loss, an earlier tremor in the hind limbs, and ...

Competing in a marathon could be considered quite the task for some, but not for one Amyotrophic Lateral Sclerosis (ALS) ...

Barbara Goodfriend, 83, opted for medical aid in dying after being diagnosed with ALS. The New Jersey widow ended her life in ...